NewAmsterdam Pharma says late-stage trial for cholesterol drug succeeded
Dutch biotech NewAmsterdam Pharma (NASDAQ:NAMS) announced Wednesday that its oral anti-cholesterol therapy containing ...
FierceBiotech2d
NewAmsterdam’s cholesterol drug scores another phase 3 win—and disappoints investors again
NewAmsterdam, which reported another phase 3 win in July, plans to use the data to file for approval. However, as happened in ...
Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss
Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...
BioWorld2d
Newamsterdam’s obicetrapib combo nails phase III LDL-C endpoints
It all comes down to outcomes,” said Michael Davidson, CEO of Newamsterdam Pharma Co. NV, which hailed “robust” and “consistent” data from its phase III study testing a fixed-dose combination of CETP ...
'Powerful' cholesterol-lowering spice doctor says is 'as effective as statins'
Dr Eric Berg DC, who is known as The Knowledge Doc, has shared the 'amazing benefits' of taking half a teaspoon of a superfood that reduces cholesterol and can be found in your kitchen cupboard ...
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
Too Old to Operate4d
Polypharmacy and Drug Effects on Aβ Fibrillation in Neurodegenerative Diseases
The following is a summary of “Highly prevalent geriatric medications and their effect on β-amyloid fibril formation,” ...
Seeking Alpha2d
NewAmsterdam Pharma says late-stage trial for cholesterol drug succeeded
Dutch biotech NewAmsterdam Pharma (NASDAQ:NAMS) announced Wednesday that its oral anti-cholesterol therapy containing experimental drugs obicetrapib and ezetimibe reached all co-primary endpoints ...